Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-08-14

AUTHORS

M Cho, H Uemura, S-C Kim, Y Kawada, K Yoshida, Y Hirao, N Konishi, S Saga, K Yoshikawa

ABSTRACT

MN/CA9 is a cancer-related gene, frequently activated in human renal cell carcinomas (RCCs). To reveal the activation mechanism, we investigated the relationship between methylation status of the MN/CA9 promoter region and gene expression using 13 human RCCs, and examined the effect of in vitro CpG methylation on the MN/CA9 promoter activity using a human RCC cell line (SK-RC-44), expressing MN/CA9. MN/CA9 expression was evaluated by RT-PCR and observed in 10 of 13 RCCs (77%). A total of 9 out of 10 MN/CA9 -positive RCCs (90%) contained clear cell components. Methylation status of 6 CpGs in the MN/CA9 promoter region was decided by using the bisulfite genomic sequencing protocol. Out of 13 RCCs 9 (69%) showed partial hypomethylation of the CpG at –74 bp, while the other 4 RCCs and 3 normal kidney tissue samples showed complete methylation. Hypomethylation of the CpG at –74 bp was strongly correlated with MN/CA9 expression. Luciferase assay revealed that the MN/CA9 promoter activity was strongly suppressed by methylation of the CpG at –74 bp. These findings suggest that hypomethylation of the CpG at –74 bp in the MN/CA9 promoter region might play an important role in this gene activation of human RCC. © 2001 Cancer Research Campaign http://www.bjcancer.com More... »

PAGES

563-567

Identifiers

URI

http://scigraph.springernature.com/pub.10.1054/bjoc.2001.1951

DOI

http://dx.doi.org/10.1054/bjoc.2001.1951

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038009142

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11506497


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Methylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Primers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Promoter Regions, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reverse Transcriptase Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcriptional Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "M", 
        "id": "sg:person.0745662234.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745662234.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uemura", 
        "givenName": "H", 
        "id": "sg:person.01051464055.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051464055.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "S-C", 
        "id": "sg:person.0626540020.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626540020.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawada", 
        "givenName": "Y", 
        "id": "sg:person.01035711247.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035711247.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "K", 
        "id": "sg:person.016163315562.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016163315562.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hirao", 
        "givenName": "Y", 
        "id": "sg:person.01005701151.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005701151.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Department of Pathology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Second Department of Pathology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konishi", 
        "givenName": "N", 
        "id": "sg:person.01005567302.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005567302.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Department of Pathology, Aichi Medical University, Aichi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411234.1", 
          "name": [
            "Second Department of Pathology, Aichi Medical University, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saga", 
        "givenName": "S", 
        "id": "sg:person.01023357016.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023357016.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Department of Pathology, Aichi Medical University, Aichi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411234.1", 
          "name": [
            "Second Department of Pathology, Aichi Medical University, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshikawa", 
        "givenName": "K", 
        "id": "sg:person.0766017060.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766017060.02"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm0795-686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016345098", 
          "https://doi.org/10.1038/nm0795-686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036723960", 
          "https://doi.org/10.1038/sj.bjc.6690757"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-08-14", 
    "datePublishedReg": "2001-08-14", 
    "description": "MN/CA9 is a cancer-related gene, frequently activated in human renal cell carcinomas (RCCs). To reveal the activation mechanism, we investigated the relationship between methylation status of the MN/CA9 promoter region and gene expression using 13 human RCCs, and examined the effect of in vitro CpG methylation on the MN/CA9 promoter activity using a human RCC cell line (SK-RC-44), expressing MN/CA9. MN/CA9 expression was evaluated by RT-PCR and observed in 10 of 13 RCCs (77%). A total of 9 out of 10 MN/CA9 -positive RCCs (90%) contained clear cell components. Methylation status of 6 CpGs in the MN/CA9 promoter region was decided by using the bisulfite genomic sequencing protocol. Out of 13 RCCs 9 (69%) showed partial hypomethylation of the CpG at \u201374\u2009bp, while the other 4 RCCs and 3 normal kidney tissue samples showed complete methylation. Hypomethylation of the CpG at \u201374\u2009bp was strongly correlated with MN/CA9 expression. Luciferase assay revealed that the MN/CA9 promoter activity was strongly suppressed by methylation of the CpG at \u201374\u2009bp. These findings suggest that hypomethylation of the CpG at \u201374\u2009bp in the MN/CA9 promoter region might play an important role in this gene activation of human RCC. \u00a9 2001 Cancer Research Campaign http://www.bjcancer.com", 
    "genre": "article", 
    "id": "sg:pub.10.1054/bjoc.2001.1951", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "85"
      }
    ], 
    "keywords": [
      "renal cell carcinoma", 
      "human renal cell carcinoma", 
      "MN/CA9 expression", 
      "MN/CA9", 
      "CA9 promoter activity", 
      "CA9 expression", 
      "human RCC cell lines", 
      "clear cell component", 
      "kidney tissue samples", 
      "normal kidney tissue samples", 
      "RCC cell lines", 
      "methylation status", 
      "cell carcinoma", 
      "cancer-related genes", 
      "bisulfite genomic sequencing protocol", 
      "promoter activity", 
      "RT-PCR", 
      "tissue samples", 
      "promoter region", 
      "cell lines", 
      "genomic sequencing protocol", 
      "CA9", 
      "CpG", 
      "hypomethylation", 
      "cell components", 
      "partial hypomethylation", 
      "gene expression", 
      "expression", 
      "status", 
      "carcinoma", 
      "CpG methylation", 
      "important role", 
      "complete methylation", 
      "total", 
      "activity", 
      "gene activation", 
      "methylation", 
      "activation", 
      "sequencing protocol", 
      "findings", 
      "luciferase", 
      "activation mechanism", 
      "BP", 
      "genes", 
      "protocol", 
      "role", 
      "effect", 
      "mechanism", 
      "region", 
      "samples", 
      "relationship", 
      "lines", 
      "components"
    ], 
    "name": "Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma", 
    "pagination": "563-567", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038009142"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1054/bjoc.2001.1951"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11506497"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1054/bjoc.2001.1951", 
      "https://app.dimensions.ai/details/publication/pub.1038009142"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_334.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1054/bjoc.2001.1951"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2001.1951'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2001.1951'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2001.1951'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2001.1951'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      22 PREDICATES      94 URIs      83 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1054/bjoc.2001.1951 schema:about N2131f4dc49ea4c36b063e29d93ef45d9
2 N2625a6a2b5834ca99697cb48c9b446df
3 N443e7095f28543598ba25a27b2f6df1d
4 N44ff32ee28734ae88b5edee9f5e20c41
5 N64a9354995454e659407fd4929defff2
6 N78ef859833ce4b4f87604ce849751f21
7 N7c569bc5181b44f79b13ca53725d2c8c
8 N90c17da7a2da4b1ab1d889d56f56131c
9 Nac5bd550bcc749769578a716f6f97172
10 Ncfa8e06e91c54e04b16aaf4a70e8adf8
11 Ne4ef85754392413180250632c329ea4f
12 Ned5909eeb3424435adbecb51073e82ed
13 anzsrc-for:11
14 anzsrc-for:1112
15 anzsrc-for:1117
16 schema:author Nc751252d6d24475493c3665df1e0f754
17 schema:citation sg:pub.10.1038/nm0795-686
18 sg:pub.10.1038/sj.bjc.6690757
19 schema:datePublished 2001-08-14
20 schema:datePublishedReg 2001-08-14
21 schema:description MN/CA9 is a cancer-related gene, frequently activated in human renal cell carcinomas (RCCs). To reveal the activation mechanism, we investigated the relationship between methylation status of the MN/CA9 promoter region and gene expression using 13 human RCCs, and examined the effect of in vitro CpG methylation on the MN/CA9 promoter activity using a human RCC cell line (SK-RC-44), expressing MN/CA9. MN/CA9 expression was evaluated by RT-PCR and observed in 10 of 13 RCCs (77%). A total of 9 out of 10 MN/CA9 -positive RCCs (90%) contained clear cell components. Methylation status of 6 CpGs in the MN/CA9 promoter region was decided by using the bisulfite genomic sequencing protocol. Out of 13 RCCs 9 (69%) showed partial hypomethylation of the CpG at –74 bp, while the other 4 RCCs and 3 normal kidney tissue samples showed complete methylation. Hypomethylation of the CpG at –74 bp was strongly correlated with MN/CA9 expression. Luciferase assay revealed that the MN/CA9 promoter activity was strongly suppressed by methylation of the CpG at –74 bp. These findings suggest that hypomethylation of the CpG at –74 bp in the MN/CA9 promoter region might play an important role in this gene activation of human RCC. © 2001 Cancer Research Campaign http://www.bjcancer.com
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree true
25 schema:isPartOf N5e737b3fa1744b709cf487072b41a589
26 Nce42762e380541a8afc6ec4bd2ce5029
27 sg:journal.1017082
28 schema:keywords BP
29 CA9
30 CA9 expression
31 CA9 promoter activity
32 CpG
33 CpG methylation
34 MN/CA9
35 MN/CA9 expression
36 RCC cell lines
37 RT-PCR
38 activation
39 activation mechanism
40 activity
41 bisulfite genomic sequencing protocol
42 cancer-related genes
43 carcinoma
44 cell carcinoma
45 cell components
46 cell lines
47 clear cell component
48 complete methylation
49 components
50 effect
51 expression
52 findings
53 gene activation
54 gene expression
55 genes
56 genomic sequencing protocol
57 human RCC cell lines
58 human renal cell carcinoma
59 hypomethylation
60 important role
61 kidney tissue samples
62 lines
63 luciferase
64 mechanism
65 methylation
66 methylation status
67 normal kidney tissue samples
68 partial hypomethylation
69 promoter activity
70 promoter region
71 protocol
72 region
73 relationship
74 renal cell carcinoma
75 role
76 samples
77 sequencing protocol
78 status
79 tissue samples
80 total
81 schema:name Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
82 schema:pagination 563-567
83 schema:productId N652cffa679584f47b5eeaea25f92dc20
84 N92f2e91b1a3c45809933a1ecc9a90b16
85 Ndff6772cd96e491ab64f46f0df9245a9
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038009142
87 https://doi.org/10.1054/bjoc.2001.1951
88 schema:sdDatePublished 2022-05-20T07:21
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N9b945804e31a47a0964da0b4156e5a85
91 schema:url https://doi.org/10.1054/bjoc.2001.1951
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N1e3e42516b814cc3908f6da13a180abf rdf:first sg:person.01051464055.75
96 rdf:rest N312d86d634b14c60977d1141bb5d304b
97 N2131f4dc49ea4c36b063e29d93ef45d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Gene Expression Regulation, Neoplastic
99 rdf:type schema:DefinedTerm
100 N2625a6a2b5834ca99697cb48c9b446df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name DNA, Neoplasm
102 rdf:type schema:DefinedTerm
103 N312d86d634b14c60977d1141bb5d304b rdf:first sg:person.0626540020.57
104 rdf:rest N4e7fb253738541e3bb0d9a27bd9632cf
105 N443e7095f28543598ba25a27b2f6df1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Kidney Neoplasms
107 rdf:type schema:DefinedTerm
108 N44ff32ee28734ae88b5edee9f5e20c41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Tumor Cells, Cultured
110 rdf:type schema:DefinedTerm
111 N4e7fb253738541e3bb0d9a27bd9632cf rdf:first sg:person.01035711247.12
112 rdf:rest Ne6a09cc0438d4785858aee0739a997e8
113 N5e737b3fa1744b709cf487072b41a589 schema:volumeNumber 85
114 rdf:type schema:PublicationVolume
115 N64a9354995454e659407fd4929defff2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name DNA Primers
117 rdf:type schema:DefinedTerm
118 N652cffa679584f47b5eeaea25f92dc20 schema:name doi
119 schema:value 10.1054/bjoc.2001.1951
120 rdf:type schema:PropertyValue
121 N69ce8ca5e10146aeae4f04ce61927b34 rdf:first sg:person.01005701151.48
122 rdf:rest N968f21c222084c6ba9f1cb8e240c23e0
123 N7138846651b5467ab45e14b62e9b4fcf rdf:first sg:person.01023357016.70
124 rdf:rest N947e025049994e30b5b34721a12addeb
125 N78ef859833ce4b4f87604ce849751f21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Promoter Regions, Genetic
127 rdf:type schema:DefinedTerm
128 N7c569bc5181b44f79b13ca53725d2c8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name DNA Methylation
130 rdf:type schema:DefinedTerm
131 N90c17da7a2da4b1ab1d889d56f56131c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Transcriptional Activation
133 rdf:type schema:DefinedTerm
134 N92f2e91b1a3c45809933a1ecc9a90b16 schema:name dimensions_id
135 schema:value pub.1038009142
136 rdf:type schema:PropertyValue
137 N947e025049994e30b5b34721a12addeb rdf:first sg:person.0766017060.02
138 rdf:rest rdf:nil
139 N968f21c222084c6ba9f1cb8e240c23e0 rdf:first sg:person.01005567302.78
140 rdf:rest N7138846651b5467ab45e14b62e9b4fcf
141 N9b945804e31a47a0964da0b4156e5a85 schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 Nac5bd550bcc749769578a716f6f97172 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Nc751252d6d24475493c3665df1e0f754 rdf:first sg:person.0745662234.99
147 rdf:rest N1e3e42516b814cc3908f6da13a180abf
148 Nce42762e380541a8afc6ec4bd2ce5029 schema:issueNumber 4
149 rdf:type schema:PublicationIssue
150 Ncfa8e06e91c54e04b16aaf4a70e8adf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Up-Regulation
152 rdf:type schema:DefinedTerm
153 Ndff6772cd96e491ab64f46f0df9245a9 schema:name pubmed_id
154 schema:value 11506497
155 rdf:type schema:PropertyValue
156 Ne4ef85754392413180250632c329ea4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Reverse Transcriptase Polymerase Chain Reaction
158 rdf:type schema:DefinedTerm
159 Ne6a09cc0438d4785858aee0739a997e8 rdf:first sg:person.016163315562.78
160 rdf:rest N69ce8ca5e10146aeae4f04ce61927b34
161 Ned5909eeb3424435adbecb51073e82ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Carcinoma, Renal Cell
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
168 schema:name Oncology and Carcinogenesis
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
171 schema:name Public Health and Health Services
172 rdf:type schema:DefinedTerm
173 sg:journal.1017082 schema:issn 0007-0920
174 1532-1827
175 schema:name British Journal of Cancer
176 schema:publisher Springer Nature
177 rdf:type schema:Periodical
178 sg:person.01005567302.78 schema:affiliation grid-institutes:grid.410814.8
179 schema:familyName Konishi
180 schema:givenName N
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005567302.78
182 rdf:type schema:Person
183 sg:person.01005701151.48 schema:affiliation grid-institutes:grid.410814.8
184 schema:familyName Hirao
185 schema:givenName Y
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005701151.48
187 rdf:type schema:Person
188 sg:person.01023357016.70 schema:affiliation grid-institutes:grid.411234.1
189 schema:familyName Saga
190 schema:givenName S
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023357016.70
192 rdf:type schema:Person
193 sg:person.01035711247.12 schema:affiliation grid-institutes:grid.410814.8
194 schema:familyName Kawada
195 schema:givenName Y
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035711247.12
197 rdf:type schema:Person
198 sg:person.01051464055.75 schema:affiliation grid-institutes:grid.410814.8
199 schema:familyName Uemura
200 schema:givenName H
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051464055.75
202 rdf:type schema:Person
203 sg:person.016163315562.78 schema:affiliation grid-institutes:grid.410814.8
204 schema:familyName Yoshida
205 schema:givenName K
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016163315562.78
207 rdf:type schema:Person
208 sg:person.0626540020.57 schema:affiliation grid-institutes:grid.410814.8
209 schema:familyName Kim
210 schema:givenName S-C
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626540020.57
212 rdf:type schema:Person
213 sg:person.0745662234.99 schema:affiliation grid-institutes:grid.410814.8
214 schema:familyName Cho
215 schema:givenName M
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745662234.99
217 rdf:type schema:Person
218 sg:person.0766017060.02 schema:affiliation grid-institutes:grid.411234.1
219 schema:familyName Yoshikawa
220 schema:givenName K
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766017060.02
222 rdf:type schema:Person
223 sg:pub.10.1038/nm0795-686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016345098
224 https://doi.org/10.1038/nm0795-686
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/sj.bjc.6690757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036723960
227 https://doi.org/10.1038/sj.bjc.6690757
228 rdf:type schema:CreativeWork
229 grid-institutes:grid.410814.8 schema:alternateName Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara
230 Second Department of Pathology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara
231 schema:name Department of Urology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara
232 Second Department of Pathology, Nara Medical University, 840 Shijo-cho, 634-8522, KashiharaNara
233 rdf:type schema:Organization
234 grid-institutes:grid.411234.1 schema:alternateName Second Department of Pathology, Aichi Medical University, Aichi, Japan
235 schema:name Second Department of Pathology, Aichi Medical University, Aichi, Japan
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...